453 related articles for article (PubMed ID: 24046830)
1. Diffusion-weighted MRI for differential diagnosis in gallbladder lesions with special reference to ADC cut-off values.
Yoshioka M; Watanabe G; Uchinami H; Miyazawa H; Abe Y; Ishiyama K; Hashimoto M; Nakamura A; Yamamoto Y
Hepatogastroenterology; 2013 Jun; 60(124):692-8. PubMed ID: 24046830
[TBL] [Abstract][Full Text] [Related]
2. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
[TBL] [Abstract][Full Text] [Related]
3. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
Kang TW; Kim SH; Park HJ; Lim S; Jang KM; Choi D; Lee SJ
Clin Radiol; 2013 Oct; 68(10):992-1001. PubMed ID: 23622795
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
[TBL] [Abstract][Full Text] [Related]
5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of gallbladder cancer.
Kim SJ; Lee JM; Kim H; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Jul; 38(1):127-37. PubMed ID: 23281048
[TBL] [Abstract][Full Text] [Related]
7. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM
Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887
[TBL] [Abstract][Full Text] [Related]
8. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.
Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Sakoguchi T; Kinoshita Y; Takeshima Y; Abe N; Akiyama Y; El-Ghoriany AI; Abd Alla AK; El-Sharkawy MA; Arita K; Kurisu K; Yamasaki F
Eur J Radiol; 2011 Nov; 80(2):412-7. PubMed ID: 20580505
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
11. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
12. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy.
Zhang Y; Chen J; Shen J; Zhong J; Ye R; Liang B
Clin Radiol; 2013 Mar; 68(3):224-31. PubMed ID: 22316593
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging to differentiate malignant from benign gallbladder disorders.
Kitazume Y; Taura S; Nakaminato S; Noguchi O; Masaki Y; Kasahara I; Kishino M; Tateishi U
Eur J Radiol; 2016 Apr; 85(4):864-73. PubMed ID: 26971436
[TBL] [Abstract][Full Text] [Related]
16. High b-value diffusion-weighted MRI in differentiation between benign and malignant polypoid gallbladder lesions.
Irie H; Kamochi N; Nojiri J; Egashira Y; Sasaguri K; Kudo S
Acta Radiol; 2011 Apr; 52(3):236-40. PubMed ID: 21498356
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
18. ADC measurement of abdominal organs and lesions using parallel imaging technique.
Yoshikawa T; Kawamitsu H; Mitchell DG; Ohno Y; Ku Y; Seo Y; Fujii M; Sugimura K
AJR Am J Roentgenol; 2006 Dec; 187(6):1521-30. PubMed ID: 17114546
[TBL] [Abstract][Full Text] [Related]
19. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
